Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Luts Läkarkonsult AB
AB
Active
Org 5568429160
Stora Algatan 6, 223 50
Lund
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2011 · 15 years old
1 employees
Monitor
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Luts Läkarkonsult AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
5M
4M
2M
1M
0M
2021: 3M
3M
2021
2022: 2M (-33% vs 2021)
2M
-33%
2022
2023: 4M (+100% vs 2022)
4M
+100%
2023
2024: 4M (0% vs 2023)
4M
0%
2024
2025: 3M (-25% vs 2024)
3M
-25%
2025
EBITDA
SEK millions
2M
1M
0M
-1M
-2M
2021: 1M
1M
2021
2022: 1M (0% vs 2021)
1M
0%
2022
2023: 0M (-100% vs 2022)
0M
-100%
2023
2024: -1M
-1M
2024
2025: 0M (+100% vs 2024)
0M
+100%
2025
Income statement
SEK thousands
Item
2025
2024
2023
2022
2021
Revenue
3 144
3 839
4 100
2 484
2 575
Staff expenses
−2 731
−3 998
−3 213
−1 254
—
EBITDA
105
−754
390
608
1 037
Depreciation & amort.
−55
−18
−31
−37
−30
EBIT
50
−772
359
570
1 007
Net financials
181
616
227
534
180
Profit before tax
434
384
464
929
928
Tax
−82
−2
−76
−109
−167
Net profit
352
383
388
821
761
Balance sheet
SEK thousands
Item
2025
2024
2023
2022
2021
Total assets
4 824
5 369
7 830
7 123
6 604
Equity
1 965
3 113
5 270
4 882
4 541
Long-term debt
—
—
—
—
0
Short-term debt
1 580
775
538
341
338
Total debt
1 580
775
538
341
338
Financial ratios
5-year trend
EBITDA margin
3,3 %
This company
15,8 %
Market median
This company
Market median
79% below market
2021
2025
Equity ratio
40,7 %
This company
38,2 %
Market median
This company
Market median
7% above market
2021
2025
Return on equity
17,9 %
This company
18,4 %
Market median
This company
Market median
3% below market
2021
2025
Net profit margin
11,2 %
This company
8,1 %
Market median
This company
Market median
38% above market
2021
2025
Asset turnover
0,65×
This company
1,12×
Market median
This company
Market median
42% below market
2021
2025
Debt / equity
1,45×
This company
0,62×
Market median
This company
Market median
134% above market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
View
PDF
More on Luts Läkarkonsult AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
